Furthermore, miR-148a delivered by exosomes may promote cancer cell proliferation and metastasis by targeting CADM1 to activate STAT3 pathway, which suggests a predictor and therapeutic target role of exosomal miR-148a in glioma patients [81]. Here, STAT3 is linked to glioma.